Normal view MARC view ISBD view

Significance of l-carnitine for human health. [electronic resource]

By:

Adeva-Andany, María M

Contributor(s):

Producer: 20180409Description: 578-594 p. digitalISSN:

1521-6551

Subject(s):

Online resources:

Available from publisher's website

In: IUBMB life vol. 69

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Review

There are no comments on this title.

to post a comment.

Back to results

41 Treatment of hepatocellular carcinoma.
by Forner, Alejandro
42 Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.
by Villanueva, Augusto
43 Current strategy for staging and treatment: the BCLC update and future prospects.
by Forner, Alejandro
44 New challenges in clinical research on hepatocellular carcinoma.
by Díaz-González, Álvaro
45 Approach of the patient with a liver mass.
by Rodríguez de Lope, Carlos
46 A rare cause of systemic inflammatory response syndrome.
by Caballol, Berta
47 Systemic therapy for hepatocellular carcinoma: the issue of treatment stage migration and registration of progression using the BCLC-refined RECIST.
by Reig, Maria
48 Management of HCC.
by de Lope, Carlos Rodríguez
49 Treatment of early hepatocellular carcinoma: Towards personalized therapy.
by Tremosini, Silvia
50 Clinical presentation, diagnosis and staging of cholangiocarcinoma.
by Forner, Alejandro
51 Clinical decision making and research in hepatocellular carcinoma: pivotal role of imaging techniques.
by Bruix, Jordi
52 Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US.
by Darnell, Anna
53 Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence.
by Raoul, Jean-Luc
54 Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
by Rimola, Jordi
55 Controversies in the management of hepatocellular carcinoma.
by Forner, Alejandro
56 Ileal carcinoid tumor as a cause of massive lower-GI bleeding: the role of capsule endoscopy.
by Forner, Alejandro
57 Postprogression survival of patients with advanced hepatocellular carcinoma: rationale for second-line trial design.
by Reig, Maria
58 Early dermatologic adverse events predict better outcome in HCC patients treated with sorafenib.
by Reig, Maria
59 Prospective evaluation of gadoxetic acid magnetic resonance for the diagnosis of hepatocellular carcinoma in newly detected nodules ≤2 cm in cirrhosis.
by Ayuso, Carmen
60 [Recommendations for the management of Sorafenib in patients with hepatocellular carcinoma].
by Reig, María